Monolithic Power Systems Inc vs 10X Genomics Inc — how do they compare? Monolithic Power Systems Inc trades at $1,381.5 (market cap $65.28B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Monolithic Power Systems Inc is far larger — about 11.9× 10X Genomics Inc's market cap, and Monolithic Power Systems Inc pays a 0.6% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| MPWR | TXG | |
|---|---|---|
Market Cap | $65.28B | $5.48B |
Sector | Utilities | Health |
52-Week High | $1.69K | $45.80 |
52-Week Low | $711.24 | $11.34 |
Enterprise Value | $63.94B | $5.02B |
Dividend Yield | 0.6% | — |
Signals from Pluang's Aura AI — not financial advice
MPWR trades at $1,328.80, up 1.28% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 22.98% net margin and robust cash flow, but carries high valuation multiples like a P/E of 93.92. Analyst consensus is overwhelmingly bullish with an $1,810 price target, though news includes both AI infrastructure optimism and legal investigations.
Outlook remains positive given earnings momentum and AI-driven demand, but risks include stretched valuations and ongoing legal scrutiny. The stock offers growth exposure but requires monitoring of execution and market sentiment shifts.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →